SCMRSA: a New Approach for Identifying and Analyzing Anti-MRSA Peptides Using Estimated Propensity Scores of

Phasit Charoenkwan1, Sakawrat Kanthawong2, Nalini Schaduangrat3

  • 1Modern Management and Information Technology, College of Arts, Media and Technology, Chiang Mai University, Chiang Mai 50200, Thailand.

ACS Omega
|September 19, 2022
PubMed

Insights

A new computational tool, SCMRSA, efficiently identifies anti-methicillin-resistant Staphylococcus aureus (MRSA) peptides using sequence data. This method offers a cost-effective alternative to experimental approaches for discovering novel antimicrobial peptides.

Area of Science:

  • Biochemistry and Molecular Biology
  • Computational Biology and Bioinformatics
  • Drug Discovery and Development

Background:

  • Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), is a significant cause of infections.
  • Antimicrobial peptides are promising therapeutic candidates due to their broad-spectrum activity.
  • Experimental identification of anti-MRSA peptides is costly and time-consuming.

Purpose of the Study:

  • To develop a computational approach for identifying and characterizing anti-MRSA peptides using only sequence information.
  • To provide a user-friendly webserver for broader accessibility and application of the developed tool.

Main Methods:

  • Developed SCMRSA, a computational method utilizing an interpretable scoring card method (SCM) and dipeptide propensity scores.
  • Did not require 3D structural information for peptide identification.
  • Evaluated performance against existing machine learning classifiers.

Main Results:

  • SCMRSA achieved high accuracy (0.960) and a Matthews correlation coefficient of 0.848 on an independent test dataset.
  • The method outperformed several machine learning-based classifiers.
  • SCMRSA-derived propensity scores offered insights into the functional mechanisms of anti-MRSA peptides.

Conclusions:

  • SCMRSA is an effective and efficient computational tool for identifying anti-MRSA peptides.
  • The developed webserver facilitates community-wide use for screening novel peptide therapeutics.
  • SCMRSA represents a valuable open-source resource for accelerating the discovery of anti-MRSA agents.